模拟禁食饮食对2型糖尿病患者心脏MRI结构和功能的影响
这项前瞻性Fasting In diabetes Treatment试验的二次分析纳入82例2型糖尿病患者,随机分为每月5天模拟禁食饮食组或常规护理组,随访12个月,用3.0 T MRI评估左心室几何和功能。结果显示模拟禁食饮食在6个月时降低左心室质量,在12个月时改善舒张功能指标E/A和Ea,且E/A改善与HbA1c降低相关。
要点
- 模拟禁食饮食可改善2型糖尿病患者左心室舒张功能(E/A和Ea升高)。
- E/A改善与HbA1c降低正相关,与HDL胆固醇变化负相关。
- 左心室质量在6个月时下降但12个月时未维持,舒张功能改善更持久。
关键影像表现/征象
- 模拟禁食饮食组6个月时左心室质量较对照组降低(平均差-5.47 g,95% CI:-9.19,-1.75;P = .005),但12个月时无差异(P = .83)。
- 模拟禁食饮食组舒张末期容积保持稳定,与对照组相比平均差为7.75 mL(95% CI:0.19,15.32;P = .045)。
- 12个月时模拟禁食饮食组E/A较对照组增加(平均差0.27,95% CI:0.04,0.50;P = .02),二尖瓣环早期峰值速度Ea增加(平均差0.84 cm/sec,95% CI:-0.02,1.67;P = .04)。
- 未观察到其他治疗效应(所有P > .05)。
诊断标准与关键数值
- 左心室舒张功能评估采用四维血流MRI测量的E/A比值和二尖瓣环早期峰值速度Ea。
- E/A变化与HbA1c变化呈正相关(标准化β = 0.47,P = .01),与高密度脂蛋白胆固醇变化呈负相关(标准化β = -0.55,P = .01)。
临床应用与阅片要点
- 在2型糖尿病患者随访中,可关注模拟禁食饮食对左心室舒张功能指标的改善,尤其是E/A和Ea的变化。
- 解读心脏MRI舒张功能时,结合血糖控制(HbA1c)和血脂变化综合评估。
局限性
- 本研究为二次分析,样本量有限(82例),可能影响统计效能。
- 研究仅纳入2型糖尿病患者,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To evaluate the effects of a monthly 5-day fasting-mimicking diet (FMD) for 1 year on left ventricular (LV) geometry and function in individuals with type 2 diabetes (T2D). Materials and Methods This secondary analysis of the prospective Fasting In diabetes Treatment trial (ClinicalTrials.gov identifier no. NCT03811587) included individuals with T2D randomized to monthly 5-day FMD or usual care for 12 months (November 2018-July 2020). MRI (3.0 T) was performed at baseline, 6 months, and 12 months. LV geometry and systolic function were assessed from two-dimensional cine images, and diastolic function was assessed from four-dimensional flow MRI. Intention-to-treat linear mixed models and linear regression were used to evaluate treatment effects and LV-metabolic associations. Results A total of 82 participants (mean age, 62.9 years ± 8.5 [SD]; 43 female) were included. FMD reduced LV mass at 6 months (mean difference, -5.47 g [95% CI: -9.19, -1.75]; P = .005) but not at 12 months (P = .83). End-diastolic volume remained stable in the FMD group versus controls (mean difference, 7.75 mL [95% CI: 0.19, 15.32]; P = .045). Both the early-to-late peak filling ratio (E/A) (mean difference, 0.27 [95% CI: 0.04, 0.50]; P = .02) and the mitral annular early peak velocity (Ea) (mean difference, 0.84 cm/sec [95% CI: -0.02, 1.67]; P = .04) increased at 12 months. No other treatment effects were observed (all P > .05). ∆E/A was positively associated with change in hemoglobin A1c (HbA1c) level (standardized β = 0.47, P = .01) and negatively associated with changes in high-density lipoprotein cholesterol levels (standardized β = -0.55, P = .01). Conclusion FMD positively influenced LV diastolic function by increasing E/A and Ea in participants with T2D; E/A improvements were associated with reduced HbA1c levels. Keywords: MR Imaging, Cardiac, Left Ventricle, Outcomes Analysis, Metabolic Disorders, Diet, Fasting-mimicking Diet, Left Ventricle Function, Type 2 Diabetes, Cardiac Magnetic Resonance ClinicalTrials.gov identifier number NCT03811587 Supplemental material is available for this article. © RSNA, 2026.
引用
- Chen R, Westenberg JJM, van den Burg EL, et al. Effects of a Fasting-mimicking Diet on MRI-assessed Cardiac Structure and Function in Participants with Type 2 Diabetes. Radiol Cardiothorac Imaging. 2026. PMID: 42530457. doi:10.1148/ryct.250547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。